Neubauer, Steffen (Omnilab 201204 Managing Director of Universal Laborservice GmbH) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
Neubeck, Peter (Kurma Partners 201901 Partner + Head of Munich Office before TVM Capital + Novartis + McKinsey) |
Partner (venture partner) |
Eurazeo (Group) |
Germany |
Neuberger, Ralph (HUMAN Diagnostics 201402 Managing Director) |
Managing Director |
HUMAN Diagnostics Worldwide (Group) |
Germany |
Neuefeind, Torsten (Proteros Biostructures 200610 Managing Director) |
Managing Director |
Proteros (Group) |
Germany |
Neuer, Katja (MLM Medical Labs 202007 Director Business Development + Aquisgranainvest 2020205– Managing Director) |
Business Development Manager / Strategy Manager |
MLM Medical Labs (Group) |
Germany |
Neugebauer, Julia (MorphoSys 202002 Director Corp Communications + IR) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Germany |
Neuhaus, Eckhart (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
Neuhaus, Gunther (Univ Freiburg 1999 Professor + Greenovation Biotech GmbH Co-founder) |
Professor |
University of Freiburg (Albert-Ludwigs-Universität Freiburg) |
Germany |
Neujahr, Martin (Bruker Corp 201612 Head Bruker Detection CBRN business unit) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Neukirch, Falk (Vita 34 201902 CFO) |
Chief Financial Officer (CFO) |
Vita 34 (Group) |
Germany |
Neukom, Beat (Kuros Biosurgery 200808c– CFO before JnJ) |
Chief Financial Officer (CFO) |
Kuros (Group) |
Switzerland |
Neuman, Toomas (IPDx Immunoprofiling Diagnostics GmbH 201511– Managing Director) |
Managing Director |
IPDx Immunoprofiling Diagnostics GmbH |
Germany |
Neumann, Andreas (Boehringer 201510– Managing Director for HR joined 2011 as Head of Legal Dept + General Counsel) |
Human Resources Manager |
Boehringer Ingelheim (Group) |
Germany |
Neumann, Birgit (Bayer Technology Systems 200503) |
n. a. |
Bayer (Group) |
Germany |
Neumann, Björn (Monsanto 201304 Managing Director of Monsanto Agrar Deutschland GmbH) |
Managing Director |
Monsanto (Group) |
Germany |
Neumann, Lars (Proteros 201305 VP Discovery Projects + Project Manager) |
n. a. |
Proteros (Group) |
Germany |
Neumann, Peter G. (Rock Capital 202411 Managing Director) |
Managing Partner |
Rock Capital (Group) |
Germany |
Neumüller, Dirk (Biotest 201608 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Grifols (Group) |
Germany |
Neusser, Marcus (Bio-Rad Laboratories GmbH 200512) |
n. a. |
Bio-Rad (Group) |
Germany |
Neusüß, Christian (Hochschule Aalen 201001 Professor Chemistry) |
Professor |
Hochschule Aalen – Technik und Wirtschaft |
Germany |
Neville, Lindsey (Consilium 201805) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
Newble, David (TTP Group 201506– Managing Director of TTP Labtech before CEO of TAP Biosystems) |
Managing Director |
SPT Labtech (Group) |
United Kingdom (GB) |
Newell, William J. (Sutro Biopharma 201409 CEO) |
Chief Executive Officer (CEO) |
Sutro Biopharma Inc. (Nasdaq: STRO) |
United States (USA) |
Newland, Andrew (Angle plc 201409 CEO + Founder) |
Chief Executive Officer (CEO) |
Angle plc (AIM: AGL) |
United Kingdom (GB) |
Newman, Sondra S. (Repligen 202308 Global Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Repligen Corporation (Nasdaq: RGEN) |
United States (USA) |
Ney, Ursula M. (Genkyotex 201105– CEO before Antisoma COO before Charterhouse Therapeutics CEO) |
Chief Executive Officer (CEO) |
Asahi Kasei (Group) |
Switzerland |
Ng, Frankie (SGS –201505–202403 CEO STEPPED DOWN 3/24) |
Chief Executive Officer (CEO) |
SGS (Group) |
Switzerland |
Ng, Michelle (Syngenta 202304 Head External Communications) |
Public Relations Manager / Investor Relations Manager |
Syngenta (Group) |
Switzerland |
Nguyen, Anh (Medincell co-founder + Invitrogen co-founder) |
Company Founder |
MedinCell (Group) |
France |
Nguyen, Tin (Monipol 202309 Managing Director) |
Managing Director |
Monipol (Group) |
Poland |
Ni, Binhui (Ben) (BioLineRx 201708 CEO of iPharma) |
Chief Executive Officer (CEO) |
BioLineRx (Group) |
China |
Nicholls, Anthony (OpenEye Scientific 202005 CEO + Founder) |
Chief Executive Officer (CEO) |
OpenEye Scientific (Group) |
United States (USA) |
Nicholson, C. David (Bayer 201203– Head RnD at Bayer CropScience before Merck US + Schering-Plough + Organon) |
Research & Development Manager |
Bayer (Group) |
Germany |
Nicholson, David (Allergan 201604 EVP + President Global Brands RnD) |
Research & Development Manager |
Allergan (Group) |
Ireland, Republic of |
Nicholson, Jeremy (Murdoch Univ + ANPC 201909 Prof before Imperial College + MRC-NIHR Phenome Centre) |
Professor |
Murdoch University |
Australia |
Nickisch, Klaus (Evestra 200808– Managing Director of Evestra GmbH) |
Managing Director |
Evestra (Group) |
Germany |
Nickl, Wolfgang (Bayer 201804– CFO before ASML NV + Western Digital + Converge) |
Chief Financial Officer (CFO) |
Bayer (Group) |
Germany |
Nicklin, Peter (Bayer HealthCare 200508– Business Development) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
Nickolaus, Claudia (Medios 202304 Head of IR + Public Relations + ESG Commmunications formerly at Mologen) |
Public Relations Manager / Investor Relations Manager |
Medios (DE) (Group) |
Germany |
Nicols, John (Codexis 201710 CEO) |
Chief Executive Officer (CEO) |
Codexis (Group) |
United States (USA) |
Nicosia, Alfredo (NousCom 201605–201905 CEO at NousCom Srl + Co-Founder before Okairos RETIRED 5/19) |
Chief Executive Officer (CEO) |
Nouscom (Group) |
Italy |
Niebel, Volker (Sartorius 201012 Board Member of Sartorius Stedim Biotech) |
Board member |
Sartorius (Group) |
Germany |
Niebling, Anna (AntiProt GmbH 2007) |
n. a. |
AntiProt GmbH |
Germany |
Niederfeld, Thomas (Avontec 200404– joined from Carl Zeiss) |
n. a. |
Avontec GmbH |
Germany |
Niedl, Anna (Medigene 202202 before 4SC 201710 Corp Communiations + IR Officer) |
Public Relations Manager / Investor Relations Manager |
Medigene (Group) |
Germany |
Niedl, Robert (InventicsDx 202107 Managing Director) |
Managing Director |
InventicsDx GmbH |
Germany |
Nielen, Michel W. F. (Wageningen Univ 201606 Professor) |
Professor |
Wageningen University |
Netherlands |
Nielsen, Fiona G. G. (Repositive 201608 CEO) |
Chief Executive Officer (CEO) |
Neurolentech GmbH |
Austria |
Nielsen, Peder Holk (Novo Group 201407 CEO of Novozymes) |
Chief Executive Officer (CEO) |
Novonesis (Group) |
Denmark |
Niemann, Stefanie (Univ Düsseldorf 201207 Director of TTHU) |
President/Director/Head Business Group/Unit/Division |
University of Düsseldorf (Heinrich-Heine-Universität) |
Germany |
Niemann, Thomas (Hessen (govt) 201105 Project Head Hessen-Biotech at HA Hessen Agentur GmbH) |
Business Development Manager / Strategy Manager |
Hessen (Hesse) (govt region) |
Germany |
Niemeier, Eckhard (Nouscom 202412– CBO before Union Therapeutics A/S + Pieris + Grünenthal + MorphoSys + McKinsey) |
Chief Business Officer (CBO) |
Nouscom (Group) |
Switzerland |
Niemeyer, Christof M. |
n. a. |
Technical University Dortmund (TU Dortmund) |
Germany |
Niemi, Essi (UPM 202312 Product Manager Life Sciences at UPM Biomedicals Basel) |
Product Manager (personnel) |
UPM (FI) (Group) |
Switzerland |
Nietfeld, Wilfried |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Niethammer, Thomas |
n. a. |
Eurofins (Group) |
Germany |
Nieuwenhuizen, Peter (ECBF 202202) |
n. a. |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
Niewöhner, Christoph (Maqsima GmbH 201608 Managing Director) |
Managing Director |
Certina (Group) |
Germany |
Niggemann, Björn (InSphero 201311 Head of Operations) |
Chief Operating Officer (COO) |
InSphero (Group) |
Switzerland |
Nikolaev, Eugene (Russian Academy of Sciences 201209 Professor) |
Professor |
Russian Academy of Sciences (RAS/EIMB) |
Russian Federation |
Nikolich, Karoly (Alkahest 201503 CEO Circuit Therapeutics 201010– Pesident + Founder before Amnestix CEO) |
Chief Executive Officer (CEO) |
Grifols (Group) |
United States (USA) |
Nikopoulos, George (Mannin 202209 CEO) |
Chief Executive Officer (CEO) |
Mannin (Group) |
Canada |
Nilles, Michael (Henkel 202405 CDIO Henkel + Chair Henkel dx Ventures) |
n. a. |
Henkel (Group) |
Germany |
Nilsson, Henrik (Akron Molecules GmbH 201212 Mananging Director before Forward Pharma A/S + Gastrotech Pharma A/S) |
Managing Director |
Akron Molecules GmbH |
Austria |
Nimrodi, Nir (Life Technologies 201307 VP + General Manager for Food Safety + Animal Health) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
Niphut, Swantje (Indivumed 201502 Marketing Communications Manager) |
Sales Manager / Marketing Manager |
Indivumed (Group) |
Germany |
Nirnberger, Thomas (BioFi 202204– CEO before Basel Area Business & Innovation) |
Chief Executive Officer (CEO) |
BioFi AG |
Switzerland |
Nishihara, Motoo (NEC 202203 EPV CTO + Board Member) |
Chief Technology/Technical Officer (CTO) |
NEC (Group) |
Japan |
Nitsch, Roger M. (Neurimmune 201809 CEO + Co-Founder + Evotec Biosystems 199906 Scientific Advisory Board) |
Chief Executive Officer (CEO) |
Neurimmune AG |
Switzerland |
Nixon, Andrew (Boehringer Ingelheim 202311 Global Head of Biotherapeutics Discovery) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Noack, Achim (Bayer 201101 Member Board of Management of Bayer CropScience) |
Board member, executive |
Bayer (Group) |
Germany |
Nobécourt, Gilles (LCF Rothschild 201105 Partner at EdRIP) |
Partner (venture partner) |
New York Life (Group) |
France |
Noble, Andrew (Bioscribe 202012 + Noble Communications 201810) |
Public Relations Manager / Investor Relations Manager |
Noble Communications LLC |
United States (USA) |
Noble, James (Adaptimmune 201909– Non-Executive Director before CEO before MediGene + Avidex) |
Board member, non-executive |
Adaptimmune (Group) |
United Kingdom (GB) |
Noe, Mathias (Karlsruhe Institute of Technology 201006 Professor Institute for Technical Physics) |
Professor |
Karlsruhe Institute of Technology (KIT) |
Germany |
Nogai, Hendrik (Ryvu Therapeutics 202202– CMO before Bayer + Nordic Biotech Capital + Oliver Wyman) |
Chief Medical Officer (CMO) |
Ryvu Therapeutics S.A. (WSE: RVU) |
Poland |
Nohaile, Michael (Novartis 201112 Head of Novartis MDx) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
|
Noiret, Franck (LBO France 202411) |
Investment Manager |
LBO France (Group) |
France |
Nolan, Eamonn (MorphoSys 202208 Director Communications) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Germany |
Noll, Annette Gucciardo (Deutsche Bank 201808 VP Conference + Events at DB USA Core Corporation) |
Event Manager / Conference Manager |
Deutsche Bank (Group) |
Germany |
Noller, Stephan (Ubirch 202003 Managing Director (CEO)) |
Managing Director |
Ubirch GmbH |
Germany |
Nolte, Andreas (Märzhäuser 201608– Managing Director at Märzhäuser Wetzlar GmbH & Co KG before Carl Zeiss) |
Managing Director |
Märzhäuser (Group) |
Germany |
Nominacher, Bastian (Celonis 202106 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Celonis (Group) |
Germany |
Nomura, Hiroshi (Sumitomo 201910 CEO of Sumitomo Dainippon Pharma) |
Chief Executive Officer (CEO) |
Sumitomo (Group) |
Japan |
Nonhoff, Offer (Pixium Vision 202106– CFO before Trigo + Lumenis + BoneSupport + Fresenius Medical Care Israel) |
Chief Financial Officer (CFO) |
Pixium Vision S.A. |
France |
Nonomura, Kazuhika (Remiges Ventures 202209 Principal) |
Principal (venture capital) |
Remiges Ventures |
United States (USA) |
Noonan, Kathleen (ITM 202406 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
ITM (Group) |
Germany |
Noonan, Mo (Mo PR Advisory 202005– Founder before 21y at FTI Consulting) |
Public Relations Manager / Investor Relations Manager |
Mo PR Advisory Ltd. |
United Kingdom (GB) |
Noonan, Susan A. (S.A. Noonan Communications before Noonan/Russo Communications) |
Public Relations Manager / Investor Relations Manager |
S.A. Noonan Communications – Susan A. Noonan |
United States (USA) |
Noone, Philip (Aalto Bio Reagents 202205 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Ireland, Republic of |
Nordheim, Alfred (Univ Tübingen 200809) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
Nordhof, Eckard |
n. a. |
Bico (Group) |
Germany |
Nordmann, Carsten (Biomol GmbH 201108 Managing Director) |
Managing Director |
Biomol GmbH (DE) |
Germany |
Norstedt, Irene (IMI 201502 Acting Executive Director) |
President/Director/Head Business Group/Unit/Division |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
Norström, Erik (Tecan 201712c– Head of Corporate Development before Chr Hansen + Nobel Biocare + Roche) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
Northoff, Stefan (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
Noser, Hans (Hombrechtikon Systems Engineering 202406 Board Chair) |
Board member, non-executive |
Hombrechtikon Systems Engineering AG (HSE·AG) |
Switzerland |
Nota, Pieter (Philips –201707 Chief Buiness leader Personal Health business + Chief Marketing Officer LEFT 7/17) |
Chief Business Officer (CBO) |
Philips (Group) |
Netherlands |
Noth, Pascal J.-N. (Partners Group 202407 Head of Private Equity Health + Life Europe) |
Investment Manager |
Partners Group (Group) |
Switzerland |
Nothelfer, Katharina (AiCuris 202308 Public Relations) |
public relations / investor relations |
STRÜNGMANN Group (family Strüngmann) |
Germany |